niacinamide has been researched along with toxin ii (anemonia sulcata) in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Akin, I; Albers, S; Borggrefe, M; Cyganek, L; Diecke, S; Dinkel, H; El-Battrawy, I; Huang, M; Kleinsorge, M; Lan, H; Lang, S; Li, X; Liao, Z; Müller, J; Rudic, B; Utikal, J; Wieland, T; Xu, Q; Zhao, Z; Zhong, R; Zhou, X; Zimmermann, WH | 1 |
1 other study(ies) available for niacinamide and toxin ii (anemonia sulcata)
Article | Year |
---|---|
A cellular model of Brugada syndrome with SCN10A variants using human-induced pluripotent stem cell-derived cardiomyocytes.
Topics: Action Potentials; Ajmaline; Brugada Syndrome; Cardiotonic Agents; Case-Control Studies; Cellular Reprogramming Techniques; Cnidarian Venoms; Death, Sudden, Cardiac; Humans; Induced Pluripotent Stem Cells; Loss of Function Mutation; Male; Middle Aged; Morpholines; Mutation; Myocytes, Cardiac; NAV1.8 Voltage-Gated Sodium Channel; Niacinamide; Patch-Clamp Techniques; Phenotype; Tachycardia, Ventricular; Voltage-Gated Sodium Channel Blockers | 2019 |